BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36699068)

  • 21. A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia.
    Wang T; Lyu CY; Jiang YH; Dong XY; Wang Y; Li ZH; Wang JX; Xu RR
    Mol Divers; 2021 Nov; 25(4):2351-2365. PubMed ID: 32676746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scutellaria barbata D.Don and Oldenlandia diffusa (Willd.) Roxb crude extracts inhibit hepatitis-B-virus-associated hepatocellular carcinoma growth through regulating circRNA expression.
    Yang PW; Chen TT; Zhao WX; Liu GW; Feng XJ; Wang SM; Pan YC; Wang Q; Zhang SH
    J Ethnopharmacol; 2021 Jul; 275():114110. PubMed ID: 33864890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scutellaria barbata and Hedyotis diffusa herb pair for breast cancer treatment: Potential mechanism based on network pharmacology.
    Ma TT; Zhang GL; Dai CF; Zhang BR; Cao KX; Wang CG; Yang GW; Wang XM
    J Ethnopharmacol; 2020 Sep; 259():112929. PubMed ID: 32416245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular docking and network pharmacological analysis of Scutellaria baicalensis against renal cell carcinoma.
    Guo J; Mei ZW; Wang XJ; Li Q; Qin J
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11574-11586. PubMed ID: 38095405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Targets and Mechanisms of
    Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
    Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Network Pharmacology Approach to Reveal the Underlying Mechanisms of
    Zhang S; Mo Z; Zhang S; Li X
    Evid Based Complement Alternat Med; 2021; 2021():8947304. PubMed ID: 33688369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
    Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
    Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the
    Jiang N; Li H; Sun Y; Zeng J; Yang F; Kantawong F; Wu J
    Front Pharmacol; 2021; 12():618522. PubMed ID: 33746755
    [No Abstract]   [Full Text] [Related]  

  • 29. Integrating Network Pharmacology and Bioinformatics to Explore the Effects of Dangshen (
    Yu Y; Ding S; Xu X; Yan D; Fan Y; Ruan B; Zhang X; Zheng L; Jie W; Zheng S
    Drug Des Devel Ther; 2023; 17():659-673. PubMed ID: 36883114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study on the Mechanism of Competing Endogenous Network of 'Scutellaria barbata D.Don-Houttuynia cordata- Radix Scutellariae' in the Treatment of NSCLC based on Bioinformatics, Molecular Dynamics and Experimental Verification.
    Wu L; Xu B; Qi Y; Yuan C
    Curr Comput Aided Drug Des; 2024 Apr; ():. PubMed ID: 38685811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Key Target and Molecular Mechanism of the Volatile Component of
    Zhu G; Zhang J; Yang Y; Zhang H; Jin W; Su F; Liang J; Wang K; Zhang J; Chen C
    Front Pharmacol; 2021; 12():650780. PubMed ID: 33981230
    [No Abstract]   [Full Text] [Related]  

  • 32. Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Wang H; Chen W; Cui Y; Gong H; Tang A
    Aging (Albany NY); 2023 Aug; 15(15):7831-7843. PubMed ID: 37556351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
    Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W
    Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardioprotective Mechanism and Active Compounds of
    Sun X; Zhu Y; Li F; Li M; Wan G
    Comput Math Methods Med; 2022; 2022():4338260. PubMed ID: 36213575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
    Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
    J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating the Mechanisms of Pollen Typhae in the Treatment of Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking.
    Zhou R; Jin D; Zhang Y; Duan L; Zhang Y; Duan Y; Kang X; Lian F
    Evid Based Complement Alternat Med; 2022; 2022():5728408. PubMed ID: 35024051
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Li Y; Zhang J; Zhang K; Chen Y; Wang W; Chen H; Zou Z; Li Y; Dai M
    Front Oncol; 2022; 12():693395. PubMed ID: 35321425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on hepatoprotective mechanisms of Veratrilla baillonii based on network pharmacology].
    He CJ; Wang J; Liang S; Li J; Huang XJ
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1789-1799. PubMed ID: 32489062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active ingredients and molecular targets of
    Zheng Y; Ji S; Li X; Feng Q
    PeerJ; 2022; 10():e13737. PubMed ID: 35873910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology].
    Zou X; Sui Y; Tang XY; Zhang R; Shu Q; Gong T; Wu S; Sun ZW; Li WL; Qu ZY
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3597-3608. PubMed ID: 35850814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.